(Q55042019)

16 June 2018

title

Unresponsiveness to AmBisome in some Sudanese patients with kala-azar. (English)

1 reference

16 June 2018

main subject

visceral leishmaniasis

1 reference

2

Koert Ritmeijer

1 reference

16 June 2018

author name string

Marius Mueller

1

1 reference

16 June 2018

Manica Balasegaram

3

1 reference

16 June 2018

Youssif Koummuki

4

1 reference

16 June 2018

Muriel Ramirez Santana

5

1 reference

16 June 2018

Robert Davidson

6

1 reference

16 June 2018

publication date

26 May 2006

1 reference

16 June 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

16 June 2018

volume

101

1 reference

16 June 2018

issue

1

1 reference

16 June 2018

page(s)

19-24

1 reference

16 June 2018

AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Current treatment approaches to leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.02.005

10.1016/J.TRSTMH.2006.02.005

7 January 2021

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

16730363

1 reference

16 June 2018